Core Insights - During the "14th Five-Year Plan" period, China's biomanufacturing industry has experienced significant growth in scale, technology, and cluster development, with a total scale reaching 1.1 trillion yuan [1][1][1] Industry Growth - The biomanufacturing industry in China has steadily expanded, with the production of biopharmaceutical products accounting for over 70% of the global output [1][1] - The annual output value of sub-sectors such as food additives and biopharmaceuticals exceeds 400 billion yuan, establishing biomanufacturing as a new economic growth point [1][1] Technological Innovation - China's biomanufacturing sector holds over 20% of the global patent application share, indicating significant innovation capabilities [1][1] - A number of national key laboratories and industrial innovation platforms have been established, leading to the industrial application of new instruments such as domestic high-throughput gene sequencers and large-scale fermentation tanks [1][1] Industry Clusters - Regions like Beijing and Tianjin have emerged as innovation hubs for biomanufacturing, while Shandong, Heilongjiang, and Henan have developed into major manufacturing bases for bulk biopharmaceutical products [1][1] - Cities such as Chongqing and Guangdong are continuously producing original achievements in the field [1][1] - The industry has nurtured several backbone enterprises with annual revenues exceeding 10 billion yuan, along with dozens of national-level manufacturing champions and specialized "little giant" enterprises [1][1]

Core Insights - The biomanufacturing industry in China has grown significantly, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1] - The industry is expected to be a core driver of the Fourth Industrial Revolution, emphasizing the importance of biomanufacturing in fostering new productive forces and advancing new industrialization [1] - The "14th Five-Year Plan" period is projected to see continued growth in biobased materials and chemicals, with bioproduct output increasing by approximately 20% compared to the end of the "13th Five-Year Plan" [1] Industry Growth and Innovation - Significant breakthroughs in technology and product innovation have been achieved, including high-throughput gene sequencers and AI protein design platforms, leading to the commercialization of various biomanufactured products [2] - The emergence of biomanufacturing clusters, such as in Shenzhen and Hainan, showcases localized development and the establishment of major technological infrastructures [2] - The Ministry of Industry and Information Technology has announced key lists related to high-performance bioreactor innovation and pilot capabilities, which are crucial for industry advancement [3] Policy and Strategic Development - The Ministry of Industry and Information Technology aims to create a complete industrial ecosystem that supports innovation, transformation, and high-quality development in biomanufacturing [3] - The upcoming "15th Five-Year Plan" will focus on establishing a framework for biomanufacturing, including the identification of flagship products and AI applications [3] - Emphasis will be placed on enhancing scientific research and innovation to address fundamental scientific issues and engineering bottlenecks in the biomanufacturing sector [3] Recommendations for High-Quality Development - The establishment of an innovation system, modern industrial system, and management service system is recommended to accelerate high-quality development in biomanufacturing [4] - Support for diverse development routes and the cultivation of flagship products is essential for the innovation ecosystem [4] - The integration of advanced biomanufacturing technologies with various industries is crucial for optimizing and upgrading industrial structures [5]

Core Insights - The biomanufacturing industry in China has grown significantly, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1] - The industry is expected to be a core driver of the Fourth Industrial Revolution, emphasizing the importance of biomanufacturing in fostering new productive forces and advancing new industrialization [1] - The "14th Five-Year Plan" period is projected to see continued growth in biobased materials and chemicals, with bioproduct output increasing by approximately 20% compared to the end of the "13th Five-Year Plan" [1] Industry Growth and Innovation - Significant breakthroughs in technology and product innovation have been achieved, including high-throughput gene sequencers and AI protein design platforms, leading to the commercialization of various biomanufactured products [2] - The emergence of biomanufacturing clusters, such as in Shenzhen and Hainan, showcases localized development and the establishment of significant production capabilities in amino acids and marine biomanufacturing [2] - The Ministry of Industry and Information Technology has announced key lists related to high-performance bioreactor innovation and pilot capabilities, indicating a structured approach to industry advancement [3] Future Development Plans - The "15th Five-Year Plan" will focus on enhancing the biomanufacturing ecosystem, including the establishment of pilot platforms and the cultivation of composite talents in the sector [3] - Emphasis will be placed on addressing fundamental scientific issues and engineering bottlenecks in biomanufacturing, promoting deep integration of technological and industrial innovation [3] - The industry aims to expand applications in future food and healthcare sectors, leveraging advancements in biomanufacturing technologies [3] Recommendations for High-Quality Development - The establishment of a comprehensive innovation system, modern industrial system, and management service system is recommended to accelerate high-quality development in biomanufacturing [4] - Support for diverse development routes and the creation of significant biomanufactured products is essential, alongside the establishment of regional innovation platforms [4] - Financial services tailored to biomanufacturing enterprises should be developed to support market-oriented operations and the growth of specialized small and medium enterprises [5]

Core Insights - The biomanufacturing industry in China has grown significantly, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1] - The industry is expected to be a core driver of the Fourth Industrial Revolution, emphasizing the importance of biomanufacturing in fostering new productive forces and advancing new industrialization [1] - The "14th Five-Year Plan" period is projected to see continued growth in biobased materials and chemicals, with bioproduct output increasing by approximately 20% compared to the end of the "13th Five-Year Plan" [1] Industry Growth and Innovation - Significant breakthroughs in technology and product innovation have been achieved, including high-throughput gene sequencers and AI protein design platforms, leading to the commercialization of various biomanufactured products [2] - The emergence of biomanufacturing clusters, such as in Shenzhen and Hainan, showcases localized development and the establishment of significant production capabilities in amino acids and marine biomanufacturing [2] - The Ministry of Industry and Information Technology has announced key lists related to high-performance bioreactor innovation and pilot capabilities, indicating a structured approach to industry advancement [3] Policy and Strategic Development - The Ministry of Industry and Information Technology aims to create a comprehensive ecosystem for biomanufacturing, focusing on innovation, transformation support, and product quality [3] - The upcoming "15th Five-Year Plan" will outline strategies for biomanufacturing, including the establishment of pilot platforms and the cultivation of composite talents in the sector [3] - Emphasis will be placed on addressing fundamental scientific issues and engineering bottlenecks, promoting deep integration of technological and industrial innovation [4] Recommendations for High-Quality Development - The establishment of an innovation system, modern industrial system, and management service system is recommended to accelerate high-quality development in biomanufacturing [4] - Support for diverse development routes and the creation of high-energy innovation platforms tailored to regional strategies is encouraged [5] - The focus will be on enhancing the evaluation mechanisms for original products and fostering specialized small and medium enterprises in the biomanufacturing sector [5]

Core Insights - The biomanufacturing industry in China has grown significantly, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1][1][1] - Biomanufacturing is recognized as a key driver of the Fourth Industrial Revolution, with expectations for continued growth in various sub-sectors during the 14th Five-Year Plan [1][1][1] Industry Growth - The report from the China Center for Information Industry Development indicates that during the 14th Five-Year Plan, sectors such as bio-based materials, bio-based chemicals, and food additives are expected to see sustained growth, with some bulk products leading the world in production [1][1][1] - Significant breakthroughs have been achieved in self-developed high-throughput gene sequencers and high-precision gene splicing instruments, highlighting the effectiveness of technological innovation in the industry [1][1][1] Government Initiatives - The Ministry of Industry and Information Technology announced three key lists: the list of innovative task winners for high-performance bioreactors, the first batch of pilot capacity building platforms for biomanufacturing, and the first batch of landmark biomanufacturing products [1][1][1] - The Director of the Consumer Goods Industry Department emphasized that these lists aim to construct a complete industrial ecosystem, with innovative task winners acting as pioneers for industry upgrades and pilot platforms serving as accelerators for result transformation [1][1][1] - Future efforts will focus on optimizing the policy environment, increasing support, and improving the innovation ecosystem to provide solid guarantees for the development of the biomanufacturing industry [1][1][1]

摘要 ：我国《高通量基因测序仪性能测定方法》国家标准正公开征求意见。标准涵盖主流测序技术平台，规范从样本到数据的全流程技术要求，预期将提升测序 数据的准确性与可比性，为科研、临床及产业发展提供重要技术支撑。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，国家标准计划《高通量基因测序仪性能测定方法》已形成征求意见稿，现面向社会公开征求意见。该标准由全国仪器分析测试标准化技 术委员会(TC481)归口，主管部门为科学技术部。 该标准主要起草单位包括中国海关科学技术研究中心、中国食品药品检定研究院、深圳华大智造科技股份有限公司、北京林电伟业电子技术有 限公司。标准规定了高通量基因测序仪的性能测定方法，适用于以联合探针锚定聚合测序法、可逆末端终止测序法、半导体测序法等为主要技 术原理的并行测序高通量基因测序仪。 高通量测序仪作为生命科学领域的核心工具，其应用已深入基因组学、遗传病诊断、肿瘤基因突变检测、病原微生物鉴定等多个领域。数据显 示，国内高通量基因测序仪年新增装机量从2020年的约600台增长至2024年的1800台，市场应用规模显著 ...

Core Insights - Shanxi Medical University has announced procurement intentions for four types of scientific instruments, with a total budget of 114 million yuan [1][2][4]. Procurement Overview - The procurement includes advanced equipment such as: - Large animal DSA system - High-throughput gene sequencer - High-resolution gas chromatography-mass spectrometry - 8-color fluorescence sequencer - Transmission electron microscope - Fully automated multi-tissue staining machine - AI high-resolution high-content system for single-cell fluorescence [2][3]. - The expected procurement period is July to August 2025 [2][4]. Budget Allocation - The total budget for the procurement is 114 million yuan, which is aimed at enhancing the research capabilities of the university [1][2]. - Specific allocations include: - 90 ultra-low temperature freezers for biological sample storage at a cost of 5.58 million yuan [5]. - A pure water system for the technology building at a cost of 1.12 million yuan [5]. - Various small equipment for the Medical Science Academy, including fluorescence quantitative PCR instruments and gel imaging systems, totaling 1 million yuan [5].